InsidersTradesSigma
Track the Dawnrays Pharmaceutical (Holdings) Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Dawnrays Pharmaceutical (Holdings) Ltd. has published 21 public disclosures. Market capitalisation: €1.5bn. The latest transaction was disclosed on 7 September 2026 (Purchase). Among the most active insiders: Hung Yung Lai. The full history is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€121,881
20 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 821 of 29,064 companies
82.3
score / 100
Value93
Quality72
FCF yld16%
Earn yld14%
EV/EBITDA4.3x
ROE6.9%
Gross mgn50%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 September 2026
Declarations21 total
60,000 shares@ HK$0.99ShareXHKGHKEX:DA20260905E00057
104,000 shares@ HK$1.000.0069% mcap21.0% of flowShareXHKGHKEX:DA20260905E00056
60,000 shares@ HK$0.990.0040% mcap10.7% of flowShareXHKGHKEX:DA20260905E00055
104,000 shares@ HK$1.000.0069% mcap18.7% of flowShareXHKGHKEX:DA20260905E00054
72,000 shares@ HK$1.000.0049% mcap18.8% of flowShareXHKGHKEX:DA20260626E00360
72,000 shares@ HK$1.000.0049% mcap18.8% of flowShareXHKGHKEX:DA20260626E00345
36,000 shares@ HK$1.130.0027% mcap12.7% of flowShareXHKGHKEX:DA20260514E00650
36,000 shares@ HK$1.130.0027% mcap12.7% of flowShareXHKGHKEX:DA20260514E00647
52,000 shares@ HK$1.150.0039% mcap18.6% of flowShareXHKGHKEX:DA20260508E00513
52,000 shares@ HK$1.150.0039% mcap18.6% of flowShareXHKGHKEX:DA20260508E00494
8,000 shares@ HK$1.120.0006% mcap2.8% of flowShareXHKGHKEX:DA20260423E00021
8,000 shares@ HK$1.120.0006% mcap2.8% of flowShareXHKGHKEX:DA20260423E00020
44,000 shares@ HK$1.120.0032% mcap15.3% of flowShareXHKGHKEX:DA20260416E00055
44,000 shares@ HK$1.120.0032% mcap15.3% of flowShareXHKGHKEX:DA20260416E00051
20,000 shares@ HK$1.130.0015% mcap7.0% of flowShareXHKGHKEX:DA20260415E00001
20,000 shares@ HK$1.130.0015% mcap7.0% of flowShareXHKGHKEX:DA20260415E00002
40,000 shares@ HK$1.140.0030% mcap14.4% of flowShareXHKGHKEX:DA20260403E00005
40,000 shares@ HK$1.140.0030% mcap14.4% of flowShareXHKGHKEX:DA20260403E00004
84,000 shares@ HK$1.090.0060% mcap29.2% of flowShareXHKGHKEX:DA20260331E00419
84,000 shares@ HK$1.090.0060% mcap29.2% of flowShareXHKGHKEX:DA20260331E00415
21 of 21 declarations
关于 Dawnrays Pharmaceutical (Holdings) Ltd.
东瑞制药（控股）有限公司是一家专注于医药产品开发和制造的公司。该公司在香港证券交易所（XHKG）上市。